220 results on '"Marsh, J. W."'
Search Results
2. Occupational dust and radiation exposure and mortality from stomach cancer among German uranium miners, 1946–2003
3. Liver Preservation With Machine Perfusion and a Newly Developed Cell-Free Oxygen Carrier Solution Under Subnormothermic Conditions
4. Laparoscopic major hepatectomy: pure laparoscopic approach versus hand-assisted technique
5. Safety of Liver Resection in the Elderly: How Important Is Age?
6. Surgical Management of Leiomyosarcoma of the Inferior Vena Cava
7. Extended-spectrum beta-lactamase-producing Klebsiella spp. in a neonatal intensive care unit: risk factors for the infection and the dynamics of the molecular epidemiology
8. Liver Transplantation Using Donation After Cardiac Death Donors: Long-Term Follow-Up from a Single Center
9. Cryptococcosis in liver and kidney transplant recipients receiving anti-thymocyte globulin or alemtuzumab
10. Erratum to: Prevalence of Nonalcoholic Steatohepatitis Among Patients with Resectable Intrahepatic Cholangiocarcinoma
11. Genetic toxicity in dab Limanda limanda from the North Sea
12. Antioxidant enzymes in liver of dab Limanda limanda from the North Sea
13. EDUCATIONAL INTELLIGENCE
14. Military Railway Equipment
15. Intrahepatic bile duct strictures after human orthotopic liver transplantation: Recurrence of primary sclerosing cholangitis or unusual presentation of allograft rejection?
16. THE MAYAK WORKER DOSIMETRY SYSTEM (MWDS-2013): HOW TO WEIGHT THE ABSORBED DOSE TO DIFFERENT LUNG REGIONS IN THE CALCULATION OF LUNG DOSE.
17. TECHNICAL RECOMMENDATIONS FOR MONITORING INDIVIDUALS FOR OCCUPATIONAL INTAKES OF RADIONUCLIDES.
18. EURADOS-IDEAS GUIDELINES (VERSION 2) FOR THE ESTIMATION OF COMMITTED DOSES FROM INCORPORATION MONITORING DATA.
19. A review of lung–to–blood absorption rates for radon progeny.
20. Note on the autocorrelation coefficient as a test statistic for assessment of the goodness-of-fit of biokinetic models to multiple bioassay data sets.
21. Dosimetric calculations for uranium miners for epidemiological studies.
22. Particle clearance in the alveolar–interstitial region of the human lungs: model validation.
23. Results of an internal dose assessment intercomparison exercise after a EURADOS/IAEA training course.
24. EURADOS coordinated action on research, quality assurance and training of internal dose assessments.
25. INTERNAL DOSE ASSESSMENTS: UNCERTAINTY STUDIES AND UPDATE OF IDEAS GUIDELINES AND DATABASES WITHIN CONRAD PROJECT.
26. INTERNAL DOSIMETRY: TOWARDS HARMONISATION AND COORDINATION OF RESEARCH.
27. DOSOMITRIC MODELS USED IN THE ALPHA-RISK PROJECT TO QUANTIFY EXPOSURE OF URANIUM MINERS TO RADON GAS AND ITS PROGENY.
28. AVOIDING BIASED ESTIMATES OF DOSE WHEN NOTHING IS KNOWN ABOUT THE TIME OF INTAKE.
29. EVALUATION OF SCATTERING FACTOR VALUES FOR INTERNAL DOSE ASSESSMENT FOLLOWING THE IDEAS GUIDELINES: PRELIMINARY RESULTS.
30. ERIDAS, A COMPUTER PROGRAM FOR RAPID CALCULATION OF INTERNAL DOSES FROM MEASUREMENTS OF PEOPLE IN AN EMERGENCY.
31. THE AUTOCORRELATION COEFFICIENT AS A TOOL FOR ASSESSING GOODNESS OF FIT BETWEEN BIOASSAY PREDICTIONS AND MEASUREMENT DATA.
32. COORDINATION OF RESEARCH ON INTERNAL DOSIMETRY IN EUROPE: THE CONRAD PROJECT.
33. ASSESSMENT OF INTAKES AND DOSES TO WORKERS FOLLOWED FOR 15 YEARS AFTER ACCIDENTAL INHALATION OF 60Co.
34. Role of basiliximab in the prevention of acute cellular rejection in adult to adult living-related liver transplantation: a single center experience.
35. OBTAINING AN UNBIASED ESTIMATE OF INTAKE IN ROUTINE MONITORING WHEN THE TIME OF INTAKE IS UNKNOWN.
36. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?
37. Screening for cerebral aneurysm in patients with polycystic liver disease.
38. Should hepatomas be treated with hepatic resection or transplantation?
39. FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER TRANSPLANTATION.
40. Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation.
41. The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: A pilot study.
42. Cultured hepatoma cells as a model system for studying insulin processing and biologic responsiveness.
43. Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma?
44. Predicting the risk of tumor recurrence following transplantation for hepatocellular carcinoma.
45. Orthotopic liver transplantation for alcoholic cirrhosis.
46. A Validated Model for Predicting Outcome after Liver Transplantation: Implications on Transplanting the Extremely Sick.
47. EURADOS coordinated action on research, quality assurance and training of internal dose assessments.
48. PREEMPTIVE THERAPY WITH VALGANCICLOVIR FOR CYTOMEGALOVIRUS-SERONEGATIVE LIVER TRANSPLANT RECIPIENTS OF CYTOMEGALOVIRUS-SEROPOSITIVE ALLOGRAFTS: A SINGLE CENTER EXPERIENCE.
49. 17 TO 20 YEARS LONGITUDINAL FOLLOW-UP OF 1000 CONSECUTIVE PRIMARY LIVER TRANSPLANT UNDER TACROLIMUS.
50. DEPRESSIVE SYMPTOMS, HOST IMMUNITY, AND SURVIVAL IN HEPATITIS B AND/OR C PATIENTS EVALUATED FOR ORTHOTOPIC LIVER TRANSPLANTATION.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.